| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.02 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.03 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |